Generics & Specialities Ltd

What Generics & Specialities Ltd does

Generics & Specialities Limited is a privately-held African pharmaceutical distribution group founded in 1991 by Sanjiv Kapoor. The company sources, markets, and distributes ethically sourced, FDA-compliant pharmaceuticals and medical consumables across five African markets: Mauritius, Tanzania, Mozambique, Angola, and Nigeria, reaching over 300 million people. Operations are executed through five wholly-owned national subsidiaries (Generics & Specialities entities in each country plus a Mauritian regional office), with on-the-ground regulatory, legal, warehousing, and sales teams in each market. The customer base is decentralized and consists of hospitals, pharmacies, and dispensaries served via field sales forces, with a retail consumer channel layered on through own-brand sub-brands.

The company's core capabilities are infrastructure-heavy rather than technology-platform-heavy: cold-chain warehousing built out over the last 10 years, transportation assets including own vehicles and port-side operations, partnerships with clearing and forwarding agencies, and FDA-compliant registration infrastructure supported by in-country legal teams. The product portfolio includes an own-brand "Generics" line covering 350+ pharmaceutical SKUs, plus two sub-brands — Generics Wellness (home personal care) and Herbal Naturals (all-natural oral, skin, and liquid medications) — distributed alongside a curated set of principal-supplier brands from 35+ global manufacturers including Sanofi, Dr. Reddy's, Aurobindo, Biocon, Sinopharm, CSPC, Panacea Biotec, Piramal, Bharat Serums, and Kedrion.

The revenue model is predominantly transactional pharmaceutical distribution (one-time license / transaction-fee based), with a go-to-market built on direct enterprise field sales to hospitals, pharmacies, and dispensaries across the five countries. Pricing is not publicly disclosed and is characterized as "reasonable" with a focus on FDA-compliant ethical sourcing. Leadership is founder-controlled: Sanjiv Kapoor as Chairman and Group Managing Director, with a professional management bench including Group CEO Pradheep Cherilath (ex-Axa Parenterals, 33 years pharma experience), Group CFO Rajesh Kumar (Chartered Accountant, 24+ years finance leadership), and Director Kartik Kapoor (Vassar / IE Business School, ex-IMF) signaling next-generation family succession.

Name

Generics & Specialities Ltd

Legal name

Generics & Specialities Limited

Website

https://genericsgroup.net

Company type

Private

Founded year

1991

Operating status

Operating

Short description

Generics & Specialities Ltd is a private African pharmaceutical distribution group, founded 1991, that sources, markets, and distributes FDA-compliant pharmaceuticals and medical consumables across five African markets (Angola, Mauritius, Mozambique, Nigeria, Tanzania), reaching 300 million people via hospitals, pharmacies, and dispensaries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

akta.pro secondary industries

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA), Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE)

Keywords

• Pharmaceutical distribution
• Medical consumables supply
• Cold chain warehousing
• Own brand generics
• Healthcare distribution Africa

Headquarters

HQ city

Dar Es Salaam

HQ country

Tanzania

HQ region

Africa

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Distribution: Distribution of ethically sourced pharmaceutical products and medical consumables to hospitals, pharmacies and dispensaries across African markets. The company imports, markets and distributes products from regulatory compliant companies globally.
2. Own Brand Pharmaceuticals: Sale of company's own branded pharmaceutical products including 'Generics' brand with over 350 pharmaceutical products, 'Generics Wellness' personal care range, and 'Herbal Naturals' all-natural ingredient medications.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Generics & Specialities sources, imports, markets, and distributes pharmaceuticals and medical consumables across five African markets (Angola, Mauritius, Mozambique, Nigeria, and Tanzania). The company sells its own Generics brand of 350+ pharmaceutical products for hospitals, pharmacies, and dispensaries, along with the Generics Wellness personal care line and the Herbal Naturals all-natural medication line, and also distributes products from global pharmaceutical principals.

Product overview

The company operates three core product lines: Generics (own brand of 350+ pharmaceuticals for hospitals, pharmacies, and dispensaries), Generics Wellness (personal care products for home use), and Herbal Naturals (natural ingredient oral medications, skin applications, and liquid medications). The company also provides pharmaceutical distribution services including compliance, warehousing, distribution, transportation, and staffing across African markets.

Differentiator

Problem solved

Functional benefit

Brands

• Generics: Own brand consisting of over 350 pharmaceuticals for a range of medical applications for hospitals, pharmacies and dispensaries.
• Generics Wellness
• Herbal Naturals

Products and services

• Generics Pharmaceutical Brand The company's own 'Generics' brand consisting of over 350 pharmaceutical products for a range of medical applications, sold to hospitals, pharmacies, and dispensaries across five African markets.
• Generics Wellness Personal care product line evolved from the increasing need for families to manage personal care at home; reaches consumers through retail channels across African markets.
• Herbal Naturals Product line comprising all-natural ingredient oral medications, skin applications, and liquid medications; offers an alternative medication range distributed through retail channels.
• Pharmaceutical and Medical Consumables Distribution End-to-end distribution of ethically sourced, FDA-compliant pharmaceutical products and medical consumables to hospitals, pharmacies, and dispensaries across Angola, Mauritius, Mozambique, Nigeria, and Tanzania, reaching over 300 million people. Includes regulatory compliance, cold-chain warehousing, transportation, and last-mile delivery via an in-house sales force.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

40 partnerships are on record, tiered minor and core.

• KedrionminorOthersInternational pharmaceutical company featured on the Generics & Specialities partners page. Kedrion specializes in plasma-derived products.
• SanoficoreOthersMajor global pharmaceutical company partnership. Sanofi is a featured principal partner of Generics & Specialities.
• FlamingominorOthersHealthcare products company (Flamingo Health) featured as a partner on the Generics & Specialities partners page.
• WelleadminorOthersMedical devices company featured as a partner on the Generics & Specialities partners page.
• ZIMminorOthersPharmaceutical company (ZIM Labs) featured as a partner on the Generics & Specialities partners page.
• ILKOminorOthersTurkish pharmaceutical company featured as a partner on the Generics & Specialities partners page.
• Axa ParenteralscoreOthersAxa Parenterals is a featured principal partner. The Group CEO previously served as Head of East and Southern Africa at Axa Parenterals.
• Biological EminorOthersIndian pharmaceutical company featured as a partner on the Generics & Specialities partners page.
• TaishominorOthersJapanese pharmaceutical company featured as a partner on the Generics & Specialities partners page.
• S-KantminorOthersPharmaceutical company featured as a partner on the Generics & Specialities partners page.
• Beta DrugsminorOthersIndian pharmaceutical company featured as a partner on the Generics & Specialities partners page.
• NEM LabsminorOthersPharmaceutical company featured as a partner on the Generics & Specialities partners page.
• BiodealminorOthersPharmaceutical company featured as a partner on the Generics & Specialities partners page.
• TroikaaminorOthersIndian pharmaceutical company featured as a partner on the Generics & Specialities partners page.
• Dr. Reddy'scoreOthersMajor Indian multinational pharmaceutical company featured as a principal partner of Generics & Specialities.
• IngacoreOthersInga Pharma featured as a principal partner on the Generics & Specialities partners page.
• MSN LabscoreOthersIndian pharmaceutical company featured as a principal partner of Generics & Specialities.
• Panacea BioteccoreOthersMajor Indian vaccine and pharmaceutical company featured as a principal partner of Generics & Specialities.
• BioconcoreOthersLeading Indian biopharmaceuticals company featured as a principal partner of Generics & Specialities.
• PiramalcoreOthersPiramal Enterprises featured as a principal partner on the Generics & Specialities partners page.
• AngiplastcoreOthersMedical devices company featured as a principal partner of Generics & Specialities.
• SinopharmcoreOthersChina's state-owned pharmaceutical giant featured as a principal partner of Generics & Specialities.
• RenovacoreOthersRenova Lifescience featured as a principal partner on the Generics & Specialities partners page.
• AurobindocoreOthersMajor Indian pharmaceutical company featured as a principal partner of Generics & Specialities.
• Bharat SerumscoreOthersIndian biopharmaceutical company featured as a principal partner of Generics & Specialities.
• AmantacoreOthersIndian pharmaceutical company featured as a principal partner on the Generics & Specialities partners page.
• AlembiccoreOthersIndian pharmaceutical company featured as a principal partner of Generics & Specialities.
• CSPCcoreOthersChinese pharmaceutical company (CSPC Pharmaceutical Group) featured as a principal partner of Generics & Specialities.
• BalcoreOthersBal Pharma featured as a principal partner on the Generics & Specialities partners page.
• BlissgvscoreOthersIndian pharmaceutical company featured as a principal partner of Generics & Specialities.
• LincolncoreOthersLincoln Pharmaceuticals featured as a principal partner on the Generics & Specialities partners page.
• MehtascoreOthersMehta Healthcare featured as a principal partner on the Generics & Specialities partners page.
• SparshcoreOthersSparsh Biotech featured as a principal partner on the Generics & Specialities partners page.
• FourrtscoreOthersIndian pharmaceutical company featured as a principal partner of Generics & Specialities.
• GalphacoreOthersIndian pharmaceutical company featured as a principal partner on the Generics & Specialities partners page.
• GalenticcoreOthersPharmaceutical company featured as a principal partner of Generics & Specialities.
• Ear IndiacoreOthersIndian pharmaceutical company featured as a principal partner on the Generics & Specialities partners page.
• ReyoungcoreOthersChinese pharmaceutical company featured as a principal partner of Generics & Specialities.
• Scott-EdilcoreOthersIndian pharmaceutical company featured as a principal partner on the Generics & Specialities partners page.
• Organic IndustriescoreOthersOrganic Group company featured as a principal partner of Generics & Specialities.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Others

• Sanofi: Global pharmaceutical major and a featured principal partner. Comparable as a principal whose innovator and generics portfolio is distributed through Generics & Specialities; relevant as both a revenue dependency and a structural relationship shaping product mix.
• Dr. Reddy's Laboratories: Indian multinational generics manufacturer listed as a principal partner of Generics & Specialities. Comparable as a principal supplier whose portfolio is distributed through Generics & Specialities and that could in theory bypass the distributor as Africa volumes scale.
• Sinopharm: China's state-owned pharmaceutical giant and a principal partner. Comparable as both a supply source and a strategic threat: Sinopharm has the capital and global reach to internalize African distribution should it choose to bypass intermediaries like Generics & Specialities.

Direct peers

• Imperial Health Sciences: South Africa-based pharmaceutical and healthcare distributor serving sub-Saharan African markets. Most direct comparability: same core business of regulated pharma warehousing, distribution, and sales-force coverage to hospitals and pharmacies across multiple African countries.

Broad incumbents

• Cipla: Indian multinational with a long-standing Africa focus, distributing generics through local partners and own channels. Comparable as a principal-level competitor whose generics portfolio is sold into the same hospitals, pharmacies, and tenders across Generics & Specialities' markets.
• Cardinal Health: US-headquartered pharmaceutical distributor serving hospitals, pharmacies, and health systems. Comparable on the regulated distribution, warehousing, and channel-management model that Generics & Specialities replicates at smaller scale in Africa.
• Aspen Pharmacare: Largest African-headquartered pharmaceutical manufacturer and distributor with deep presence across sub-Saharan Africa. Comparable because it combines local manufacturing, branded generics, and distribution at scale across the same geographies Generics & Specialities serves.
• McKesson: Global pharmaceutical wholesaler and distributor operating at massive scale across North America and Europe. Comparable on business model (regulated drug distribution, cold chain, hospital channel), though operating geographies are different; useful as a structural benchmark for distribution economics.

Regional players

• Fidson Healthcare: Nigeria-listed pharmaceutical company manufacturing and distributing branded generics across Nigeria. Comparable as a regional competitor operating in Generics & Specialities' most populous market with overlapping hospital and pharmacy channels.
• Emzor Pharmaceutical Industries: Nigerian pharmaceutical manufacturer and distributor with strong domestic footprint and growing West Africa presence. Comparable as a regional competitor combining local manufacturing with branded generics distribution in one of Generics & Specialities' key markets (Nigeria).

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/generics-specialities-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Generics & Specialities Ltd